Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cronos Group Inc (CRON.TO)

Cronos Group Inc (CRON.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cronos Group Inc 4491 Concession Rd 12 Stayner ON L0M 1S0 CAN

https://www.thecronosgroup.com P: 416-504-0004

Sector:

Medical

Description:

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,300,145
Shares Outstanding, K 379,051
% of Institutional Shareholders 4.39%

Financials:

Annual Sales, $ 146,587 K
Annual Net Income, $ -9,447 K
Last Quarter Sales, $ 44,531 K
Last Quarter Net Income, $ -1,816 K

Growth:

1-Year Return 24.19%
3-Year Return 28.36%
5-Year Return -72.89%
5-Year Revenue Growth 25.70%

Per-Share Information:

Most Recent Earnings 0.00 on 02/26/26
Next Earnings Date 02/27/25
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Year -109.09%
Dividend Payout Ratio 0.00%

CRON.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 29.50
Price/Earnings to Growth N/A
Return-on-Equity % -0.88%
Return-on-Assets % -0.80%
Profit Margin % -6.44%
Debt/Equity 0.00
Price/Sales 6.62
Price/Book 0.88
Book Value/Share 3.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar